STING1 and acute myeloid leukemia: Moreover, pan-cancer analysis based on the TCGA and GTEx databases showed that STING mRNA was significantly differentially expressed in both normal and tumor tissues in 25 out of 29 tumor types, including AML (Figure 1F).